Literature DB >> 19113821

Sestrin 2 is not a reductase for cysteine sulfinic acid of peroxiredoxins.

Hyun Ae Woo1, Soo Han Bae, Sunjoo Park, Sue Goo Rhee.   

Abstract

The active-site cysteine of 2-Cys peroxiredoxins (Prxs), a subgroup of the Prx family, is reversibly hyperoxidized to cysteine sulfinic acid during catalysis with concomitant loss of peroxidase activity. The reduction of sulfinic 2-Cys Prx enzymes, the first known biologic of such a reaction, has been reported to be catalyzed by either sulfiredoxin (Srx) or sestrin (Sesn) 2. The 13-kDa Srx and 60-kDa Sesn 2 show no sequence similarity, however. Whereas the reductase function of Srx has been confirmed by several studies, such is not the case for Sesn 2. We have now shown that (a) recombinant Sesn 2 did not catalyze the reduction of sulfinic Prx I in vitro, whereas Srx did; (b) overexpression of Sesn 2 in HeLa or A549 cells did not affect the reduction of 2-Cys Prxs, whereas overexpression of Srx markedly increased the reduction rate; and (c) the rate of sulfinic 2-Cys Prx reduction in embryonic fibroblasts derived from Sesn 2-knockout mice did not differ from that in those derived from wild-type mice. These results suggest that, unlike Srx, Sesn 2 is not a sulfinic Prx reductase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19113821     DOI: 10.1089/ars.2008.2360

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  45 in total

1.  The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1.

Authors:  Lynne Chantranupong; Rachel L Wolfson; Jose M Orozco; Robert A Saxton; Sonia M Scaria; Liron Bar-Peled; Eric Spooner; Marta Isasa; Steven P Gygi; David M Sabatini
Journal:  Cell Rep       Date:  2014-09-25       Impact factor: 9.423

Review 2.  Sestrins orchestrate cellular metabolism to attenuate aging.

Authors:  Jun Hee Lee; Andrei V Budanov; Michael Karin
Journal:  Cell Metab       Date:  2013-09-19       Impact factor: 27.287

3.  Sestrin family of genes and their role in cancer-related fatigue.

Authors:  Velda J Gonzalez-Mercado; Brooke L Fridley; Leorey N Saligan
Journal:  Support Care Cancer       Date:  2018-03-12       Impact factor: 3.603

4.  Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction.

Authors:  Nels Olson; Milena Hristova; Nicholas H Heintz; Karen M Lounsbury; Albert van der Vliet
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-16       Impact factor: 5.464

5.  The potential of sestrins as therapeutic targets for diabetes.

Authors:  Xiaocheng Charlie Dong
Journal:  Expert Opin Ther Targets       Date:  2015-05-05       Impact factor: 6.902

Review 6.  Biochemical Basis of Sestrin Physiological Activities.

Authors:  Allison Ho; Chun-Seok Cho; Sim Namkoong; Uhn-Soo Cho; Jun Hee Lee
Journal:  Trends Biochem Sci       Date:  2016-05-10       Impact factor: 13.807

Review 7.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

Review 8.  Peroxiredoxins, gerontogenes linking aging to genome instability and cancer.

Authors:  Thomas Nyström; Junsheng Yang; Mikael Molin
Journal:  Genes Dev       Date:  2012-09-15       Impact factor: 11.361

Review 9.  Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin.

Authors:  Francesc X Soriano; Paul Baxter; Lyndsay M Murray; Michael B Sporn; Thomas H Gillingwater; Giles E Hardingham
Journal:  Mol Cells       Date:  2009-03-19       Impact factor: 5.034

10.  Modulation of intracellular ROS levels by TIGAR controls autophagy.

Authors:  Karim Bensaad; Eric C Cheung; Karen H Vousden
Journal:  EMBO J       Date:  2009-08-27       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.